Deutsche Bank Ag\ Elevation Oncology, Inc. Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 188,771 shares of ELEV stock, worth $120,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188,771
Previous 29,020
550.49%
Holding current value
$120,813
Previous $17,000
541.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ELEV
# of Institutions
74Shares Held
41.5MCall Options Held
700Put Options Held
27.6K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$3.84 Million0.19% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$3.05 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$2.26 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA2.97MShares$1.9 Million0.06% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.81 Million0.6% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $14.9M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...